Simplifying Global Compliance
FDAnews Drug Daily Bulletin
KV Settlement Is a Warning on False Claims, Unapproved Drugs
Dec. 15, 2011
A $17 million deal with KV Pharmaceutical to settle false claims allegations should cue drugmakers to the FDA and Justice Department’s focus on this area, officials say.
Washington Drug Letter
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing